This study is looking at how a non-invasive treatment called transcranial photobiomodulation (tPBM) affects attention in adults. tPBM uses near-infrared light (specifically 1064 nanometers) to activate the prefrontal cortex, a part of the brain. Researchers want to see if tPBM can improve attention in healthy adults and those with Attention Deficit Hyperactivity Disorder (ADHD). You can join if you are 18 years or older. The study will measure attention using a Continuous Performance Task over a period of up to two months. The study is currently unclear on its recruitment status and plans to enroll 500 participants.

Study design

This interventional study involves 500 participants and compares transcranial photobiomodulation (tPBM) with a sham (inactive) treatment.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your attention will be measured for up to two months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.